This brand name is authorized in Germany, UK.
The drug RENACET contains one active pharmaceutical ingredient (API):
1
|
UNII
Y882YXF34X - CALCIUM ACETATE
|
|
Calcium is an endogenous ion of the body essential for the maintenance of a number of physiologic processes. It participates as an integral factor in the maintenance of the functional integrity of the nervous system, in the contractile mechanisms of muscle tissue, in the clotting of blood, and in the formation of the major structural material of the skeleton. Soluble calcium salts are commonly used in the treatment of calcium deficiency. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| RENACET Film-coated tablet | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| DE | Bundesinstitut für Arzneimittel und Medizinprodukte | 00817563, 00817592, 04103375, 04103381 |
| GB | Medicines & Healthcare Products Regulatory Agency | 186136, 186141 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.